COLL
COLL
NASDAQ · Pharmaceuticals

Collegium Pharmaceutical Inc

$35.36
+0.74 (+2.14%)
As of Jun 24, 1:50 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +36.2% upside
Low Target $33.48
Average Target $48.15
High Target $61.72
Current Price $35.36
Current
$35.36
Target
$48.15
$33.48 $48.15 avg $61.72
Scenario Analysis
Bear Case
$33.48
-5.3%
Low target
Base Case
$48.15
+36.2%
Avg target
Bull Case
$61.72
+74.5%
High target
Risk/Reward
14.0x
Highly favorable
Price in Context
52-Week High
$50.79
-30.4% from high
52-Week Low
$29.11
+21.5% from low
Target vs 52W High
$48.15
-5.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%